Skip to main content
logo
Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
10.51
+0.44 (4.37%)
At close: Aug 4, 2026, 4:00 PM EDT
10.45
-0.06 (-0.57%)
Pre-market: Aug 5, 2026, 6:47 AM EDT

Candel Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
7703104064352224
Market Cap Growth
129.59%-23.66%850.14%-17.39%-76.93%-
Enterprise Value
624.51239.48317.1330.114.51142.27
Last Close Price
10.515.658.681.471.797.82

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----414.131794.84
PB Ratio
5.585.976.133.361.083.50
P/TBV Ratio
4.265.764.143.341.082.30

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----36.071138.18

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.350.940.051.050.470.01
Net Debt / Equity Ratio
-1.05-1.36-1.34-0.99-0.99-1.28
Net Debt / EBITDA Ratio
2.621.492.750.341.393.22
Net Debt / FCF Ratio
2.971.823.300.371.443.41
Asset Turnover
-0000.000.00
Quick Ratio
27.6313.312.742.5012.4815.41
Current Ratio
28.0513.492.772.5912.8115.84
Return on Equity (ROE)
-57.30%-64.58%-139.56%-125.50%-33.61%-178.06%
Return on Assets (ROA)
-34.50%-41.60%-45.08%-64.58%-41.61%-40.36%
Return on Invested Capital (ROIC)
-1271.87%-543.11%-244.18%-383.53%-663.27%-654.69%
Return on Capital Employed (ROCE)
-36.28%-52.03%-69.27%-77.48%-44.54%-43.82%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-51.17%-67.19%-9.47%-0.39%-52.72%-62.49%
Total Shareholder Return
-51.17%-67.19%-9.47%-0.39%-52.72%-62.49%
SEC Filings: 10-K · 10-Q